Acrobiosystems Co.,Ltd. (SHE:301080)
China
· Delayed Price · Currency is CNY 43.63
-1.37 (-3.04%)
Mar 9, 2026, 4:00 PM EDT
Acrobiosystems Market Cap
Acrobiosystems has a market cap or net worth of 7.30 billion as of March 9, 2026. Its market cap has increased by 10.47% in one year.
Market Cap
7.30B
Enterprise Value
5.49B
Revenue
794.52M
Ranking
n/a
PE Ratio
42.39
Stock Price
43.63
Market Cap Chart
Since October 18, 2021, Acrobiosystems's market cap has decreased from 13.51B to 7.30B, a decrease of -45.92%. That is a compound annual growth rate of -13.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 7.30B | -19.20% |
| Dec 31, 2025 | 9.04B | 71.05% |
| Dec 31, 2024 | 5.28B | -25.26% |
| Dec 29, 2023 | 7.07B | -13.93% |
| Dec 30, 2022 | 8.22B | -51.36% |
| Dec 31, 2021 | 16.89B | 25.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wuhan Keqian Biology Co.,Ltd | 7.43B |
| Zhejiang Ausun Pharmaceutical | 7.83B |
| Suzhou Fengbei Biotech Stock | 7.92B |
| Jiangsu Aidea Pharmaceutical Group | 7.13B |
| Anhui Huaheng Biotechnology | 7.99B |
| Nanjing Vazyme Biotech | 8.06B |
| Chengdu Kanghua Biological Products | 8.08B |
| Jiangxi Fushine Pharmaceutical | 8.25B |